AbClon Inc.

₩16,310As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:174900Healthcare
Country South Korea
PE (Fwd) •••
TSR 9Y CAGR 4.09%
Div yield —
ROE (40.78%)
Biotechnology
Beta (5Y) 0.80
PE TTM —
TSR TTM (24.84%)
Mkt cap ₩325.4B
ROIC (75.88%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩20,206
23.89%
(90.25%)
Hold 4|1|8|10|8
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
384.66
425.10
456.79
479.89
16.67%
18.78%
24.90%
26.58%
Revenue₩B
22.21
22.10
22.86
24.17
10.19%
4.09%
7.80%
12.89%
Peers (US$239.9M)
Cap (US$)
PE
244.4M
—
200.2M
—
Capital
TTM
5Y
10Y
Leveragex
1.178
(0.018)
(0.016)
EBIT/Intx
0.920
0.106
0.103
Own earn%
41.61
(55.84)
(51.50)
Sh yield%
46.17
4.20
3.77
Owners
Insiders/Inst%
4.69
58.25
Short interest%
1.56
SBC / revenue%
3.76
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
8
Op margin range%
9–15
$1 testx
—
Incr. ROIC%
1